Matt Davidson
Chief Development Officer, Director · ADIAL PHARMACEUTICALS, INC.
Individual
- 2026
- Jun 16, 2026
- 1
Filings (90d)
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Matt Davidson files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Coastlands Capital LP - $106K in ADIL purchases and sales in the last 12 months
- Wendy B. Young - $100K in ADIL purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Matt Davidson?
Matt Davidson is a corporate insider, tracked as Chief Development Officer, Director of ADIAL PHARMACEUTICALS, INC. (ADIL). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did Matt Davidson last file a Form 4?
The only primary Form 4 on record is dated 16 June 2026.
